Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Metformin Exerts Anti-Leukemic Effects Via Direct Inhibition Of Oncogenic Kinase Activity In Leukemia Cells Derived From Myeloproliferative Neoplasms

Ichiro Kawashima, MD, Keita Kirito, MD, PhD

Blood (2013) 122 (21): 2853.

https://doi.org/10.1182/blood.V122.21.2853.2853

Published: 2013

Journal Articles

The Genetic Landscape Of FPD/AML Revealed CDC25C Mutation As a Driver That Promotes Malignant Transformation

Akihide Yoshimi, MD, PhD, Takashi Toya, MD, Masahiro Nakagawa, MD, PhD, Masahito Kawazu, MD, PhD, Yasuhito Nannya, MD, PhD, Motoshi Ichikawa, MD, PhD, Shunya Arai, MD, PhD, Hironori Harada, MD, PhD, Kensuke Usuki, MD, PhD, Yasuhide Hayashi, MD, PhD, Etsuro Ito, MD, PhD, Keita Kirito, MD, PhD, Hideaki Nakajima, MD, PhD, Hiroyuki Mano, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2013) 122 (21): 739.

https://doi.org/10.1182/blood.V122.21.739.739

Published: 2013

Journal Articles

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

Keita Kirito, MD, PhD, Hu Yongzhen, MD, Kozue Yoshida, MD, Toru Mitsumori, MD, Kei Nakajima, MD, Yumi Nozaki, MD, Takahiro Nagashima, MD, Masae Kunitama, MD, Kumi Sakoe, PhD, Norio Komatsu, MD, PhD

Blood (2007) 110 (11): 110.

https://doi.org/10.1182/blood.V110.11.110.110

Published: 2007

Journal Articles

A Novel Inherited Single-Nucleotide Mutation in 5′-UTR in the Transcription Factor RUNX1 in Familial Platelet Disorder with Propensity To Develop Myeloid Malignancies.

Keita Kirito, MD, PhD, Toru Mitsumori, MD, Takahiro Nagashima, MD, Masae Kunitama, MD, Kei Nakajima, MD, Kozue Yoshida, MD, Yongzhen Hu, MD, Mitsuhiro Yanagai, MD, Norio Komatsu, MD,PhD

Blood (2006) 108 (11): 1917.

https://doi.org/10.1182/blood.V108.11.1917.1917

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Metformin Exerts Anti-Leukemic Effects Via Direct Inhibition Of Oncogenic Kinase Activity In Leukemia Cells Derived From Myeloproliferative Neoplasms

The Genetic Landscape Of FPD/AML Revealed CDC25C Mutation As a Driver That Promotes Malignant Transformation

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

A Novel Inherited Single-Nucleotide Mutation in 5′-UTR in the Transcription Factor RUNX1 in Familial Platelet Disorder with Propensity To Develop Myeloid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Update search

Metformin Exerts Anti-Leukemic Effects Via Direct Inhibition Of Oncogenic Kinase Activity In Leukemia Cells Derived From Myeloproliferative Neoplasms

The Genetic Landscape Of FPD/AML Revealed CDC25C Mutation As a Driver That Promotes Malignant Transformation

HIF-1 Supports the Survival of Multiple Myeloma Cells through the Induction of Survivin Gene.

A Novel Inherited Single-Nucleotide Mutation in 5′-UTR in the Transcription Factor RUNX1 in Familial Platelet Disorder with Propensity To Develop Myeloid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only